Clinical Trial Update: Swiss studY for the Treatment of COPD Patients With the Free combiNation of indacatERol and GlYcopyrroniumbromide. [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the free combination of indacaterol and glycopyrronium bromide for chronic obstructive pulmonary disease has completed, with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Indacaterol/glycopyrronium bromide (indacaterol; glycopyrronium bromide)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Obstructive Pulmonary Disease: COPD | Phase 3 | Status: COMPLETED | Results posted: 2016-02-09